These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19801961)
21. Multicentre surveillance of prevalence of the 23S rRNA A2058G and A2059G point mutations and molecular subtypes of Treponema pallidum in Taiwan, 2009-2013. Wu BR; Yang CJ; Tsai MS; Lee KY; Lee NY; Huang WC; Wu H; Lee CH; Chen TC; Ko WC; Lin HH; Lu PL; Chen YH; Liu WC; Yang SP; Wu PY; Su YC; Hung CC; Chang SY Clin Microbiol Infect; 2014 Aug; 20(8):802-7. PubMed ID: 24438059 [TBL] [Abstract][Full Text] [Related]
22. Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection. Yang CJ; Tang HJ; Chang SY; Hsieh SM; Lee KY; Lee YT; Sheng WH; Yang SP; Hung CC; Chang SC J Antimicrob Chemother; 2016 Mar; 71(3):775-82. PubMed ID: 26604241 [TBL] [Abstract][Full Text] [Related]
23. Azithromycin versus penicillin G benzathine for early syphilis. Chen XS Sex Transm Dis; 2012 Nov; 39(11):900-1. PubMed ID: 23060081 [No Abstract] [Full Text] [Related]
24. Treponema pallidum resistance to azithromycin in France: A nationwide retrospective study from 2010 to 2022. Salle R; Grange PA; Ollagnier G; Hembert R; Benhaddou N; Heller U; Dupin N J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e20-e21. PubMed ID: 37561930 [No Abstract] [Full Text] [Related]
25. Molecular Subtyping and Surveillance of Resistance Genes In Treponema pallidum DNA From Patients With Secondary and Latent Syphilis in Hunan, China. Xiao Y; Liu S; Liu Z; Xie Y; Jiang C; Xu M; Zhao F; Zeng T; Yu J; Wu Y Sex Transm Dis; 2016 May; 43(5):310-6. PubMed ID: 27100768 [TBL] [Abstract][Full Text] [Related]
26. Syphilis epidemiology in 1994-2013, molecular epidemiological strain typing and determination of macrolide resistance in Treponema pallidum in 2013-2014 in Tuva Republic, Russia. Khairullin R; Vorobyev D; Obukhov A; Kuular UH; Kubanova A; Kubanov A; Unemo M APMIS; 2016 Jul; 124(7):595-602. PubMed ID: 27102715 [TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study. Tantalo LC; Lieberman NAP; Pérez-Mañá C; Suñer C; Vall Mayans M; Ubals M; González-Beiras C; Rodríguez-Gascón A; Canut A; González-Candelas F; Mueller J; Tapia K; Greninger AL; Giacani L; Mitjà O Lancet Microbe; 2023 Dec; 4(12):e994-e1004. PubMed ID: 37827185 [TBL] [Abstract][Full Text] [Related]
28. Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Zhou P; Li K; Lu H; Qian Y; Gu X; Gong W; Tucker JD; Cohen MS Sex Transm Dis; 2010 Nov; 37(11):726-9. PubMed ID: 20644500 [TBL] [Abstract][Full Text] [Related]
29. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. Marra CM; Colina AP; Godornes C; Tantalo LC; Puray M; Centurion-Lara A; Lukehart SA J Infect Dis; 2006 Dec; 194(12):1771-3. PubMed ID: 17109351 [TBL] [Abstract][Full Text] [Related]
30. Clarithromycin treatment failure due to macrolide resistance in Treponema pallidum in a patient with primary syphilis. Woznicová V; Matejková P; Flasarová M; Zákoucká H; Valisová Z; Smajs D; Dastychová E Acta Derm Venereol; 2010 Mar; 90(2):206-7. PubMed ID: 20169316 [No Abstract] [Full Text] [Related]
31. Azithromycin-resistant syphilis-causing strains in Sydney, Australia: prevalence and risk factors. Read P; Jeoffreys N; Tagg K; Guy RJ; Gilbert GL; Donovan B J Clin Microbiol; 2014 Aug; 52(8):2776-81. PubMed ID: 24850356 [TBL] [Abstract][Full Text] [Related]
32. Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy. Tsai MS; Yang CJ; Lee NY; Hsieh SM; Lin YH; Sun HY; Sheng WH; Lee KY; Yang SP; Liu WC; Wu PY; Ko WC; Hung CC J Int AIDS Soc; 2014; 17(1):18993. PubMed ID: 25174641 [TBL] [Abstract][Full Text] [Related]
33. Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains? Šmajs D; Paštěková L; Grillová L Am J Trop Med Hyg; 2015 Oct; 93(4):678-83. PubMed ID: 26217043 [TBL] [Abstract][Full Text] [Related]
34. Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington. Grimes M; Sahi SK; Godornes BC; Tantalo LC; Roberts N; Bostick D; Marra CM; Lukehart SA Sex Transm Dis; 2012 Dec; 39(12):954-8. PubMed ID: 23191949 [TBL] [Abstract][Full Text] [Related]
35. Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. Matějková P; Flasarová M; Zákoucká H; Bořek M; Křemenová S; Arenberger P; Woznicová V; Weinstock GM; Šmajs D J Med Microbiol; 2009 Jun; 58(Pt 6):832-836. PubMed ID: 19429763 [TBL] [Abstract][Full Text] [Related]
36. Genomic epidemiology of syphilis reveals independent emergence of macrolide resistance across multiple circulating lineages. Beale MA; Marks M; Sahi SK; Tantalo LC; Nori AV; French P; Lukehart SA; Marra CM; Thomson NR Nat Commun; 2019 Jul; 10(1):3255. PubMed ID: 31332179 [TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. Martin IE; Tsang RS; Sutherland K; Tilley P; Read R; Anderson B; Roy C; Singh AE J Clin Microbiol; 2009 Jun; 47(6):1668-73. PubMed ID: 19339468 [TBL] [Abstract][Full Text] [Related]
39. Azithromcyin might not protect against Treponema pallidum infection or reactivation in HIV type 1-infected patients. Spooner K; Barthel RV; Robertson J; Merritt T; Bradley W; Taylor-Means S; Crum N; Armstrong A; Agan B Clin Infect Dis; 2005 Aug; 41(3):419-20. PubMed ID: 16007551 [No Abstract] [Full Text] [Related]